Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E18.67 EPS (ttm)0.77 Insider Own0.00% Shs Outstand834.38M Perf Week0.14%
Market Cap11.94B Forward P/E17.57 EPS next Y0.81 Insider Trans- Shs Float834.06M Perf Month-5.23%
Income639.71M PEG25.33 EPS next Q0.22 Inst Own14.46% Short Float1.32% Perf Quarter-9.66%
Sales3.60B P/S3.32 EPS this Y2.09% Inst Trans53.70% Short Ratio11.90 Perf Half Y-0.58%
Book/sh4.37 P/B3.28 EPS next Y-0.22% ROA13.14% Short Interest11.04M Perf Year3.98%
Cash/sh0.90 P/C15.87 EPS next 5Y0.74% ROE19.12% 52W Range12.90 - 16.89 Perf YTD2.90%
Dividend Est.0.10 (0.68%) P/FCF87.16 EPS past 5Y20.07% ROI17.14% 52W High-15.23% Beta0.53
Dividend TTM0.10 (0.67%) Quick Ratio1.36 Sales past 5Y8.97% Gross Margin57.16% 52W Low11.01% ATR (14)0.25
Dividend Ex-DateJul 30, 2024 Current Ratio1.92 EPS Y/Y TTM3.31% Oper. Margin21.92% RSI (14)44.22 Volatility1.17% 1.44%
Employees27048 Debt/Eq0.16 Sales Y/Y TTM10.96% Profit Margin17.79% Recom2.89 Target Price16.16
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q-16.39% Payout10.00% Rel Volume1.24 Prev Close14.47
Sales Surprise3.61% EPS Surprise-13.57% Sales Q/Q14.98% EarningsNov 05 AMC Avg Volume927.33K Price14.32
SMA200.14% SMA50-4.52% SMA200-5.41% Trades Volume1,147,292 Change-1.04%
Date Action Analyst Rating Change Price Target Change
Jan-11-24Downgrade Jefferies Buy → Underperform
Aug-29-23Downgrade HSBC Securities Buy → Hold
May-18-23Downgrade Bernstein Outperform → Mkt Perform
Mar-17-23Upgrade BofA Securities Neutral → Buy
Jan-30-23Initiated JP Morgan Underweight
Nov-14-22Downgrade Credit Suisse Neutral → Underperform
Jan-03-22Resumed BofA Securities Neutral
Jul-27-21Downgrade Credit Suisse Outperform → Neutral
Feb-02-21Upgrade Barclays Equal Weight → Overweight $56 → $70
Sep-18-20Upgrade Investec Sell → Hold
Dec-03-24 06:52AM
Nov-30-24 04:24PM
06:47AM
Nov-29-24 07:34AM
Nov-28-24 06:15AM
08:07AM Loading…
Nov-26-24 08:07AM
Nov-20-24 08:30AM
Nov-07-24 06:31AM
Nov-06-24 02:15AM
Nov-05-24 02:23PM
09:59AM
Oct-29-24 07:59PM
Oct-25-24 07:40AM
Oct-14-24 09:47AM
Oct-09-24 07:57AM
03:58AM Loading…
03:58AM
Oct-08-24 11:32AM
06:27AM
Oct-02-24 11:10AM
Oct-01-24 07:14AM
Sep-28-24 12:57PM
Aug-21-24 06:13AM
Aug-20-24 02:42PM
Jul-29-24 01:01PM
11:55AM
10:07AM
Jul-27-24 09:51AM
Jun-27-24 10:25AM
Jun-26-24 03:31PM
11:26AM
01:05PM Loading…
Jun-03-24 01:05PM
May-28-24 09:53AM
May-22-24 12:16PM
07:11AM
May-21-24 10:05AM
May-09-24 09:40AM
May-08-24 01:55PM
01:12PM
09:01AM
May-07-24 12:54PM
10:31AM
May-03-24 08:00AM
Mar-22-24 07:00AM
Mar-20-24 09:40AM
Mar-19-24 07:00AM
Feb-28-24 09:40AM
Feb-05-24 09:50AM
Feb-01-24 11:01AM
09:03AM
Jan-31-24 09:44AM
Jan-30-24 02:03PM
06:19AM
05:38AM
Jan-29-24 05:50PM
Jan-03-24 06:00AM
Dec-14-23 07:49AM
Dec-06-23 07:00AM
Nov-02-23 09:40AM
Oct-30-23 07:38AM
Oct-29-23 01:08PM
Oct-27-23 02:13PM
01:50PM
Oct-26-23 12:00PM
Oct-04-23 12:45PM
Sep-26-23 09:35AM
Sep-18-23 12:45PM
Aug-31-23 12:45PM
Aug-10-23 07:00AM
Jul-28-23 08:02AM
Jul-27-23 10:30AM
Jul-26-23 12:31PM
Jul-12-23 10:25AM
Jun-09-23 09:45PM
Jun-08-23 09:54PM
11:14AM
Jun-06-23 07:18AM
Jun-05-23 07:00AM
Jun-04-23 03:51PM
May-16-23 10:22AM
May-11-23 09:58AM
May-10-23 11:43AM
09:21AM
May-08-23 01:28PM
May-05-23 07:17AM
Apr-21-23 07:15AM
Mar-20-23 07:00AM
Feb-27-23 03:04PM
06:00AM
Feb-08-23 08:50AM
Jan-31-23 06:25PM
Jan-30-23 06:51PM
Jan-27-23 01:36PM
07:03AM
Jan-26-23 12:55PM
Jan-20-23 06:30AM
Dec-19-22 08:00AM
Oct-31-22 11:01AM
Oct-11-22 07:57AM
Sep-07-22 01:28PM
Aug-17-22 10:16AM
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Israeli ErezOfficerJul 29 '24Proposed Sale82.2965,5005,390,000Jul 29 10:55 AM